PHC-12-2014
PHC-12-2014
19 projects · €62,420,281 total EU contribution (project-level) · 26 participating organizations · 11 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€62,420,281
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (4)
- Italy (4)
- Netherlands (4)
- UK (4)
- France (3)
- IE (2)
- DK (1)
- EE (1)
- EL (1)
- Spain (1)
- SE (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- Firalis2 projects · FR
- AG1 projects · NL
- AMONETA DIAGNOSTICS1 projects · FR
- BIMIND SAS1 projects · IT
- BIOATLAS OU1 projects · EE
- BIOSENSIA1 projects · IE
- Calcivis1 projects · UK
- CT1 projects · DE
- COSTRUZIONI STRUMENTI OFTALMICI C.S.O. SRL1 projects · IT
- CYTO1 projects · UK
- DIATECH PHARMACOGENETICS S.R.L.1 projects · IT
- EPIGENOMICS1 projects · DE
Projects
Page 2 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Improved breast cancer care by innovative diagnostic test MammaPrint MammaPrint · 672570 | H2020 | €4,048,407 | €4,048,407 | Details |
Validation of clinical performance and pre-commercial development of a novel diagnostic for dental caries assessment Calcivis CAIS · 666440 | H2020 | €2,615,000 | €2,975,531 | Details |
Development of a digital diagnostics rapid Lung Maturity Test (LMT) for premature infants, to assist neonatologists in the diagnosis of Respiratory Distress Syndrome at birth SIME-LMT · 666668 | H2020 | €2,864,456 | €3,417,675 | Details |
Validation of a point-of-care H-FABP test for a rapid exclusion of Acute Myocardial Infarction in patients with cardiac complaints. RapidEx · 666666 | H2020 | €1,633,750 | €1,633,750 | Details |
Bioactive AdrenoMedullin is a Novel Outstanding Marker to Predict and Prevent Septic Shock PreventSepticShock · 666328 | H2020 | €2,137,500 | €2,137,500 | Details |
Validation of PreCursor-M for enhanced Cervical (Pre)Cancer detection VALID-SCREEN · 666800 | H2020 | €3,264,375 | €3,264,375 | Details |
Clinical validation of a serum protein biomarker signature for the early diagnosis of pancreatic cancer. IMMPACT · 672454 | H2020 | €4,244,969 | €4,244,969 | Details |
Validation of a fast and simple peripheral blood diagnostic biomarker kit for Alzheimer’s disease ADDIA · 674474 | H2020 | €4,998,625 | €804,355 | Details |
An innovative double technologies medical device for corneal diseases. MD-SD-OCT · 673447 | H2020 | €1,965,868 | €1,965,868 | Details |